FI80453C - Foerfarande foer framstaellning av terapeutiskt aktiva 1,4-dihydro-4-oxonaftyridinderivat. - Google Patents

Foerfarande foer framstaellning av terapeutiskt aktiva 1,4-dihydro-4-oxonaftyridinderivat. Download PDF

Info

Publication number
FI80453C
FI80453C FI851637A FI851637A FI80453C FI 80453 C FI80453 C FI 80453C FI 851637 A FI851637 A FI 851637A FI 851637 A FI851637 A FI 851637A FI 80453 C FI80453 C FI 80453C
Authority
FI
Finland
Prior art keywords
group
salt
compound
dihydro
fluoro
Prior art date
Application number
FI851637A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI80453B (fi
FI851637L (fi
FI851637A0 (fi
Inventor
Hirokazu Narita
Jun Nitta
Isamu Saikawa
Isao Kitayama
Hideyoshi Nagaki
Yoshinori Konishi
Yoriko Kobayashi
Mikako Shinagawa
Yasuo Watanabe
Akira Yotsuji
Shinzaburo Minami
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13845280&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI80453(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of FI851637A0 publication Critical patent/FI851637A0/fi
Publication of FI851637L publication Critical patent/FI851637L/fi
Publication of FI80453B publication Critical patent/FI80453B/fi
Application granted granted Critical
Publication of FI80453C publication Critical patent/FI80453C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FI851637A 1984-04-26 1985-04-25 Foerfarande foer framstaellning av terapeutiskt aktiva 1,4-dihydro-4-oxonaftyridinderivat. FI80453C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8496384 1984-04-26
JP59084963A JPS60228479A (ja) 1984-04-26 1984-04-26 １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩

Publications (4)

Publication Number Publication Date
FI851637A0 FI851637A0 (fi) 1985-04-25
FI851637L FI851637L (fi) 1985-10-27
FI80453B FI80453B (fi) 1990-02-28
FI80453C true FI80453C (fi) 1990-06-11

Family

ID=13845280

Family Applications (1)

Application Number Title Priority Date Filing Date
FI851637A FI80453C (fi) 1984-04-26 1985-04-25 Foerfarande foer framstaellning av terapeutiskt aktiva 1,4-dihydro-4-oxonaftyridinderivat.

Country Status (30)

Country Link
JP (1) JPS60228479A (fr)
KR (1) KR870001693B1 (fr)
AR (1) AR241911A1 (fr)
AT (2) AT389698B (fr)
AU (2) AU565087B2 (fr)
BE (1) BE902279A (fr)
CH (1) CH673458A5 (fr)
CS (1) CS250684B2 (fr)
DD (1) DD238795A5 (fr)
DE (2) DE3546658C2 (fr)
DK (1) DK165877C (fr)
EG (1) EG17339A (fr)
ES (2) ES8700256A1 (fr)
FI (1) FI80453C (fr)
FR (2) FR2563521B1 (fr)
GB (2) GB2158825B (fr)
HU (2) HU194226B (fr)
ID (1) ID21142A (fr)
IL (1) IL75021A (fr)
IT (1) IT1209953B (fr)
LU (1) LU85871A1 (fr)
NL (2) NL187314C (fr)
NO (1) NO162238C (fr)
NZ (1) NZ211895A (fr)
PH (3) PH22801A (fr)
PL (1) PL147392B1 (fr)
PT (1) PT80349B (fr)
RO (2) RO95509B (fr)
SE (2) SE463102B (fr)
ZA (1) ZA853102B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6172753A (ja) * 1984-09-18 1986-04-14 Dainippon Pharmaceut Co Ltd ピリジルケトン誘導体
AT392789B (de) * 1985-01-23 1991-06-10 Toyama Chemical Co Ltd Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten
AU576657B2 (en) * 1985-01-23 1988-09-01 Toyama Chemical Co. Ltd. Naphthyridine and pyridine derivatives
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester
EP0207420B1 (fr) * 1985-06-26 1992-05-06 Daiichi Pharmaceutical Co., Ltd. Dérivés d'acide pyridonecarboxylique
US4962112A (en) * 1987-08-04 1990-10-09 Abbott Laboratories 7-(2-methyl-4-aminopyrrolidinyl)naphthryidine and quinoline compounds
IE62600B1 (en) * 1987-08-04 1995-02-22 Abbott Lab Naphtyridine antianaerobic compounds
US4859776A (en) * 1988-03-11 1989-08-22 Abbott Laboratories (S)-7-(3-aminopyrrolidin-1-yl)-1-(ortho, para-difluorophenyl)-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid and method for its preparation
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
DE3934082A1 (de) * 1989-10-12 1991-04-18 Bayer Ag Chinoloncarbonsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung als antivirale mittel
CA2100242A1 (fr) * 1991-01-14 1992-07-15 Soon K. Moon Composes a base de quinolone; methode de preparation
FR2692577B1 (fr) * 1992-05-26 1996-02-02 Bouchara Sa Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.
KR940014395A (ko) * 1992-12-09 1994-07-18 강박광 신규한 퀴놀론 유도체 및 그의 제조방법
KR0148277B1 (ko) * 1993-01-18 1998-11-02 채영복 신규한 플루오르퀴놀론계 유도체 및 그의 제조방법
AU4272793A (en) * 1993-04-24 1994-11-21 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and process for preparing the same
KR950018003A (ko) * 1993-12-09 1995-07-22 스미스클라인 비참 피엘씨 신규한 퀴놀론 유도체 및 그의 제조 방법
DE69531305T2 (de) * 1994-10-20 2004-05-13 Wakunaga Seiyaku K.K. Pyridoncarboxylat- derivate oder salze davon und antibakterielle zusammensetzungen die diese als aktiven bestandteil enthalten
EP0897919B1 (fr) 1996-04-19 2004-06-16 Wakunaga Pharmaceutical Co., Ltd. Nouveaux derives de l'acide pyridonocarboxylique ou des sels de cet acide et agents antibacteriens contenant ces substances en tant que composant actif
EP0935600A1 (fr) * 1996-10-30 1999-08-18 Bayer Ag Procede de fabrication de composes de naphtyridine et nouveaux produits intermediaires
DE19713506A1 (de) 1997-04-01 1998-10-08 Bayer Ag Verfahren zur Herstellung von 2,6-Dichlor-5-fluornicotinonitril und die chemische Verbindung 3-Cyano-2-hydroxy-5-fluorpyrid-6-on-mononatriumsalz sowie dessen Tautomere
CN1343128B (zh) 1999-03-17 2010-04-21 第一制药株式会社 药物组合物
US6441182B1 (en) 1999-06-10 2002-08-27 Bayer Aktiengesellschaft Method for the production of 2,6-dichloro-5-fluoro-nicotinic acid and coarse and particularly pure 2,6-dichloro-5-fluoro-nicotinic acid
WO2001017991A1 (fr) 1999-09-02 2001-03-15 Wakunaga Pharmaceutical Co., Ltd. Derive d'acide quinolinecarboxylique ou son sel
EP1313708A1 (fr) * 2000-08-29 2003-05-28 Chiron Corporation Composes de quinoline antibacteriens et procedes d'utilisation de ceux-ci
KR100981351B1 (ko) * 2003-10-29 2010-09-10 주식회사 엘지생명과학 7-클로로-1-사이클로프로필-6-플루오로-4-옥소-1,4-디하이드로-1,8-나프티리딘-3-카복실산의 제조방법
CN101792443A (zh) * 2010-03-09 2010-08-04 北京欧凯纳斯科技有限公司 氟代喹诺酮衍生物及其制备方法和用途
JOP20190045A1 (ar) 2016-09-14 2019-03-14 Bayer Ag مركبات أميد حمض 1- أريل-نفثيريدين-3-كربوكسيليك مستبدلة في الموضع 7 واستخدامها.
CN114369092A (zh) * 2021-12-20 2022-04-19 赤峰万泽药业股份有限公司 甲苯磺酸妥舒沙星及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2125310A1 (en) * 1971-05-21 1972-11-30 Sterling Drug Inc , New York, NY (V St A) 1-alkyl-1,4-dihydro-4-oxo-1,8-naphtyridine 3-carboxylic acids antibac
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4382937A (en) 1981-02-27 1983-05-10 Dainippon Pharmaceutical Co., Ltd. Naphthyridine derivatives and their use as anti-bacterials
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
NZ210847A (en) * 1984-01-26 1988-02-29 Abbott Lab Naphthyridine and pyridopyrimidine derivatives and pharmaceutical compositions
IL74064A (en) * 1984-01-26 1988-09-30 Abbott Lab 1,7-disubstituted-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives and antibacterial compositions containing them
AU576657B2 (en) * 1985-01-23 1988-09-01 Toyama Chemical Co. Ltd. Naphthyridine and pyridine derivatives
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester

Also Published As

Publication number Publication date
JPS6320828B2 (fr) 1988-04-30
AR241911A1 (es) 1993-01-29
IL75021A0 (en) 1985-08-30
GB2191776B (en) 1990-03-28
PL147392B1 (en) 1989-05-31
NO162238C (no) 1989-12-06
AT389698B (de) 1990-01-10
AU8180487A (en) 1988-03-24
CS250684B2 (en) 1987-05-14
AU565087B2 (en) 1987-09-03
KR870001693B1 (ko) 1987-09-24
FR2614620B1 (fr) 1990-03-09
IL75021A (en) 1994-01-25
HU197571B (en) 1989-04-28
DK185685A (da) 1985-10-27
RO95509A (fr) 1988-09-30
FR2563521B1 (fr) 1989-02-03
KR850007596A (ko) 1985-12-07
FI80453B (fi) 1990-02-28
IT8548002A0 (it) 1985-04-26
SE501412C2 (sv) 1995-02-13
FR2563521A1 (fr) 1985-10-31
HU194226B (en) 1988-01-28
NL9100648A (nl) 1991-08-01
NO162238B (no) 1989-08-21
RO95509B (ro) 1988-10-01
EG17339A (en) 1989-06-30
HUT38634A (en) 1986-06-30
ATA267888A (de) 1989-09-15
GB2158825A (en) 1985-11-20
SE8804586D0 (sv) 1988-12-20
PL253108A1 (en) 1985-12-17
LU85871A1 (fr) 1985-12-16
SE8502017D0 (sv) 1985-04-25
DK185685D0 (da) 1985-04-25
ES8700256A1 (es) 1986-09-16
CH673458A5 (fr) 1990-03-15
GB8716897D0 (en) 1987-08-26
BE902279A (fr) 1985-10-25
PH25228A (en) 1991-03-27
DK165877C (da) 1993-06-21
RO91871A (fr) 1987-07-30
DK165877B (da) 1993-02-01
NL187314C (nl) 1991-08-16
NO851643L (no) 1985-10-28
DE3546658C2 (fr) 1992-04-02
SE8502017L (sv) 1985-10-27
ES8706673A1 (es) 1987-07-01
GB2191776A (en) 1987-12-23
ES551538A0 (es) 1987-07-01
PH25046A (en) 1991-01-28
ATA122485A (de) 1989-06-15
PH22801A (en) 1988-12-12
NZ211895A (en) 1988-07-28
PT80349A (en) 1985-05-01
GB2158825B (en) 1989-01-25
DE3514076C2 (fr) 1989-03-30
DE3514076A1 (de) 1985-10-31
JPS60228479A (ja) 1985-11-13
SE8804586L (sv) 1988-12-20
ES542584A0 (es) 1986-09-16
PT80349B (pt) 1987-09-30
IT1209953B (it) 1989-08-30
AU612993B2 (en) 1991-07-25
AT390258B (de) 1990-04-10
GB8510297D0 (en) 1985-05-30
FI851637L (fi) 1985-10-27
NL8501172A (nl) 1985-11-18
FR2614620A1 (fr) 1988-11-04
DD238795A5 (de) 1986-09-03
SE463102B (sv) 1990-10-08
ZA853102B (en) 1986-12-30
ID21142A (id) 1999-04-29
FI851637A0 (fi) 1985-04-25
AU4165085A (en) 1985-10-31
RO91871B (ro) 1987-07-31

Similar Documents

Publication Publication Date Title
FI80453C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 1,4-dihydro-4-oxonaftyridinderivat.
US4880806A (en) 1-Cyclopropyl-6-fluoro-7-piperazinyl-1,4-Dihydro-4-oxo-quinoline-3-carboxylic acid derivatives
US4649144A (en) Antibacterial 7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives
SK667886A3 (en) Substituted bridged diazabicycloalkylquinolonecarboxylic acids, process for producing and pharmaceutical compositions containing the same
US5091384A (en) Anti-bacterial quinolone- and naphthyridone-carboxylic acid compounds
US4806541A (en) Quinoline derivatives
AU2002233706B2 (en) Pyridopyrimidine or naphthyridine derivative
DK168439B1 (da) 1-Cyclopropyl-1,4-dihydro-4-oxo-1,8-naphthyridin-3-carboxylsyrer, deres fremstilling og lægemiddel indeholdende disse forbindelser
EP0288519A1 (fr) Agents bactericides a base d'acide naphthyridine substitues par un alkyle tertiaire - quinoleine carboxylique
EP0599240B1 (fr) Dérivés d'indol-7-carboxamides comme analgésiques
HU219581B (hu) Új piridon-karbonsav-származékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények, valamint intermedierek
CS277415B6 (en) 4-pyridone derivatives, process of their preparation and pharmaceutical preparations comprising them
CS262417B2 (en) Process for preparing new 1h,3h-pyrrolo/1,2-c/-thiazoles
CS259516B2 (en) Method of new heterocyclic compounds production
EP0178388A1 (fr) Dérivés de l'acide quinoléinecarboxylique
EP0700913B1 (fr) 5,6-dihydro-4H-imidazo(4,5,1-ij)quinolines, procédés pour leur préparation, leur usage comme médicaments, et composés intermédiaires
JPS6233176A (ja) １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩
FI82456B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1-fenyl-1,2,4-tiadiazin-1-oxidderivat.
JPS61137885A (ja) １，８−ナフチリジン誘導体、そのエステルおよびその塩
EP0221541A2 (fr) Dérivés de l'acide quinoléinonecarboxylique et leur préparation
EP0311948A2 (fr) Composés de l'acide quinolone carboxylique et leur utilisation pharmaceutique
JPH0366688A (ja) １，４―ジヒドロ―４―オキソナフチリジン化合物
JPH0348682A (ja) ピリドンカルボン酸化合物
JPH0616665A (ja) キノロンカルボン酸誘導体及び該化合物を有効成分とする抗菌剤
JPH0219380A (ja) キノロンカルボン酸化合物

Legal Events

Date Code Title Description
FG Patent granted

Owner name: TOYAMA CHEMICAL CO., LTD.

MA Patent expired